INTRACEREBRAL CRISES DURING TREATMENT OF DIABETIC-KETOACIDOSIS

被引:212
|
作者
ROSENBLOOM, AL
机构
[1] J-296, JHMHC, Gainesville
关键词
D O I
10.2337/diacare.13.1.22
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sixty-nine instances of intracerebral complications of diabetic ketoacidosis (DKA), including 29 unpublished occurrences, were analyzed to determine predictive factors, the frequency of other disorders resembling cerebral edema, the effectiveness of intervention to reduce intracranial pressure, and whether any etiologic considerations appeared valid. The review failed to implicate rate of hydration, tonicity of administered fluids, rate of correction of glycemia, or use of bicarbonate. Infants and young children (<5 yr of age) were disproportionately represented (33%), as were new-onset patients (62%). Approximately 20% of patients were found to have localized basilar edema, hemorrhage, thromboses, or infection by computed tomography scan or on postmortem examination. The histories of 50% of the patients suggested a period of dramatic neurological change preceding respiratory arrest (RA) during which intervention might be effective. Twenty-three patients were treated for increased intracranial pressure before RA; 13 patients survived in an independent functional state, and 3 survived in a severely disabled or vegetative state. Only 3 of the remaining 46 patients survived normally: 2 were untreated and never developed RA, and 1 was given mannitol at the onset of apnea. This review supports close neurological monitoring and intervention to reduce intracranial pressure when there are definite signs of neurological compromise. However, treatment appears to be successful in only 50% of patients who give sufficient warning for such intervention, and they comprised half of the study population. Therefore, prevention of DKA remains the most important goal to avoid intracerebral complications.
引用
收藏
页码:22 / 33
页数:12
相关论文
共 50 条
  • [41] INCREASED KETONE-BODY CLEARANCE DURING TREATMENT OF DIABETIC-KETOACIDOSIS
    KRENTZ, AJ
    HALE, PJ
    SINGH, BM
    NATTRASS, M
    DIABETOLOGIA, 1987, 30 (07) : A543 - A543
  • [42] INCREASED KETONE-BODY CLEARANCE DURING TREATMENT OF DIABETIC-KETOACIDOSIS
    KRENTZ, AJ
    HALE, PJ
    SINGH, BM
    NATTRASS, M
    CLINICAL SCIENCE, 1987, 73 : P44 - P44
  • [43] MORE ON THE ROLE OF INSULIN IN THE TREATMENT OF DIABETIC-KETOACIDOSIS
    MATZ, R
    DIABETOLOGIA, 1987, 30 (10) : 826 - 826
  • [44] METABOLIC EFFECTS OF BICARBONATE IN THE TREATMENT OF DIABETIC-KETOACIDOSIS
    HALE, PJ
    CRASE, J
    NATTRASS, M
    BMJ-BRITISH MEDICAL JOURNAL, 1984, 289 (6451): : 1035 - 1038
  • [45] TREATMENT OF DIABETIC-KETOACIDOSIS WITH CONTINUOUS INFUSION ON INSULIN
    REYES, MZ
    ESCANDON, JC
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1979, 31 (04): : 429 - 430
  • [46] PLASMA PHOSPHORUS AND MAGNESIUM VALUES DURING TREATMENT OF SEVERE DIABETIC-KETOACIDOSIS
    IONESCUTIRGOVISTE, C
    BRUCKNER, I
    MIHALACHE, N
    IONESCU, C
    REVUE ROUMAINE DE MEDECINE-MEDECINE INTERNE, 1981, 19 (01): : 63 - 68
  • [47] HIGH-DENSITY LIPOPROTEIN CHANGES DURING TREATMENT OF DIABETIC-KETOACIDOSIS
    JOVEN, J
    RUBIESPRAT, J
    DELAFIGUERA, M
    VALDES, M
    VILLABONA, CM
    CHACON, P
    MASDEU, S
    DIABETES & METABOLISM, 1985, 11 (02): : 102 - 105
  • [48] EPIDEMIOLOGY AND TREATMENT OF DIABETIC-KETOACIDOSIS IN A COMMUNITY POPULATION
    ELLEMANN, K
    SOERENSEN, JN
    PEDERSEN, L
    EDSBERG, B
    ANDERSEN, OO
    DIABETES CARE, 1984, 7 (06) : 528 - 532
  • [49] ACETONE METABOLISM IN HUMANS DURING DIABETIC-KETOACIDOSIS
    REICHARD, GA
    SKUTCHES, CL
    HOELDTKE, RD
    OWEN, OE
    DIABETES, 1986, 35 (06) : 668 - 674
  • [50] DIABETIC-KETOACIDOSIS IN CHILDHOOD
    ZACK, BG
    AMERICAN FAMILY PHYSICIAN, 1982, 26 (01) : 107 - 113